Sanofi Wins $17.2M Fees, Expenses After Ditching FCA Suit
Amphastar Pharmaceuticals Inc. must pay Sanofi-Aventis $17.2 million in attorney fees, expenses and interest in its failed False Claims Act suit against the company's predecessor alleging the blood thinner Lovenox was...To view the full article, register now.
Already a subscriber? Click here to view full article